Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older.
The companies said in a press statement that their request is based off two Israeli studies that show "an additional mRNA booster increases immunogenicity and lowers rates of confirmed infections and severe illness."
